Literature DB >> 29242224

Draft Genome Sequence of the First NDM-4-Producing Escherichia coli Strain (AK1), Isolated from Sewage Water of a North Indian Hospital.

Asad U Khan1, Ayesha Z Beg2, Praveen K Verma3.   

Abstract

We report here the draft genome sequence of the first isolated NDM-4-producing Escherichia coli strain, isolated from sewage water at a North Indian hospital. The genome has an assembly size of 5,076,053 bp, arranged in 129 contigs, with 5,271 genes and a G+C content of 50.47%.
Copyright © 2017 Khan et al.

Entities:  

Year:  2017        PMID: 29242224      PMCID: PMC5730674          DOI: 10.1128/genomeA.01366-17

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

The escalated spread of antibiotic-resistant bacteria is an alarming situation in the context of treating infection (1). Carbapenem-resistant Enterobacteriaceae strains contain an enzyme, carbapenemase, that hydrolyzes β-lactams of all classes (2). The enterobacterium Escherichia coli possesses the carbapenemase New Delhi metallo-β-lactamase (NDM), which is commonly associated with multidrug resistance genes, endowing a very high level of drug resistance and rendering it unassailable (3, 4). Here, we present the genome sequence of the NDM-4-carrying E. coli strain AK1 to understand the genes associated with its resistance and virulence and gain further information about its pathogenicity. The E. coli isolate was collected from hospital sewage in 2011 (5). The bacterial DNA was isolated using a Qiagen QIAamp DNA minikit, and GE SimpliNano, a UV-visible spectrophotometer, was used to measure the concentration and purity of the DNA. The DNA was subjected to whole-genome sequencing on an Illumina NextSeq 500 platform using the 2 × 150-bp paired-end read length sequencing protocol. The raw sequence data were further analyzed by FastQ for quality control purposes. SPAdes version 3.10.1 was used to create a de novo assembly with a genome coverage of 266.181×. Genome annotation was performed with the NCBI Prokaryotic Genome Annotation Pipeline using a best-placed reference protein set and GeneMarkS+ methodology. The genome was further analyzed with VirulenceFinder (6), CARD/ARDB (7), BLASTn searches for O and H alleles, and plasmid multilocus sequence typing (http://www.pubmlst.org/plasmid) (8) for virulence factors, resistance genes, serotype, incompatibility group of plasmid, and sequence type (ST) of the isolate. The genome analysis revealed that the isolate belongs to ST315 and has the serotype O15:H7. The genome assembly consists of 129 contigs and has a sequence length of 5,076,053 bp with an overall G+C content of 50.74%. The genome was identified to have 5,271 genes, out of which 4,948 are coding sequences for proteins. Due to the unavailability of a genome sequence for E. coli ST315, a BLAST analysis of this genome was done, and the subject genome with highest identity, Escherichia coli O157:H7 strain Sakai (GenBank accession no. NC_002695), was used as the reference. The analysis of the genome revealed the presence of virulence factors associated with diarrheagenic E. coli and a very high number of resistance genes (some control two-component systems). Included in the genome is a plasmid that is 155,678 bp long with a G+C content of 52% and belongs to the incompatibility group IncF. It harbors blaNDM-4, blaCTX-M-15, and blaTEM-1b resistance genes for aminoglycosides and sulfonamide in association with class I integrons, transposons, and insertion sequence elements. Of note, E. coli ST315 belongs to human host and phylogenetic group D (9).

Accession number(s).

This whole-genome shotgun project (PRJNA397500) of E. coli strain AK1 has been deposited at DDBJ/ENA/GenBank under the accession no. NSBV00000000.
  9 in total

1.  Molecular epidemiology over an 11-year period (2000 to 2010) of extended-spectrum β-lactamase-producing Escherichia coli causing bacteremia in a centralized Canadian region.

Authors:  Gisele Peirano; Akke K van der Bij; Daniel B Gregson; Johann D D Pitout
Journal:  J Clin Microbiol       Date:  2011-12-07       Impact factor: 5.948

2.  The antibiotic resistance crisis: part 1: causes and threats.

Authors:  C Lee Ventola
Journal:  P T       Date:  2015-04

3.  Detection of bla(NDM-4) in Escherichia coli from hospital sewage.

Authors:  Asad U Khan; Shadab Parvez
Journal:  J Med Microbiol       Date:  2014-07-28       Impact factor: 2.472

Review 4.  Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention.

Authors:  Neil Gupta; Brandi M Limbago; Jean B Patel; Alexander J Kallen
Journal:  Clin Infect Dis       Date:  2011-07-01       Impact factor: 9.079

Review 5.  Carbapenem resistance: overview of the problem and future perspectives.

Authors:  Georgios Meletis
Journal:  Ther Adv Infect Dis       Date:  2016-02

6.  In silico detection and typing of plasmids using PlasmidFinder and plasmid multilocus sequence typing.

Authors:  Alessandra Carattoli; Ea Zankari; Aurora García-Fernández; Mette Voldby Larsen; Ole Lund; Laura Villa; Frank Møller Aarestrup; Henrik Hasman
Journal:  Antimicrob Agents Chemother       Date:  2014-04-28       Impact factor: 5.191

7.  Real-time whole-genome sequencing for routine typing, surveillance, and outbreak detection of verotoxigenic Escherichia coli.

Authors:  Katrine Grimstrup Joensen; Flemming Scheutz; Ole Lund; Henrik Hasman; Rolf S Kaas; Eva M Nielsen; Frank M Aarestrup
Journal:  J Clin Microbiol       Date:  2014-02-26       Impact factor: 5.948

Review 8.  Global spread of Carbapenemase-producing Enterobacteriaceae.

Authors:  Patrice Nordmann; Thierry Naas; Laurent Poirel
Journal:  Emerg Infect Dis       Date:  2011-10       Impact factor: 6.883

9.  ARDB--Antibiotic Resistance Genes Database.

Authors:  Bo Liu; Mihai Pop
Journal:  Nucleic Acids Res       Date:  2008-10-02       Impact factor: 16.971

  9 in total
  1 in total

1.  Genome analyses of blaNDM-4 carrying ST 315 Escherichia coli isolate from sewage water of one of the Indian hospitals.

Authors:  Ayesha Z Beg; Asad U Khan
Journal:  Gut Pathog       Date:  2018-05-24       Impact factor: 4.181

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.